Imaging biomarkers for evaluating tumor response: RECIST and beyond
Abstract Response Evaluation Criteria in Solid Tumors (RECIST) is the gold standard for assessment of treatment response in solid tumors. Morphologic change of tumor size evaluated by RECIST is often correlated with survival length and has been considered as a surrogate endpoint of therapeutic effic...
Saved in:
Main Authors: | Ching-Chung Ko (Author), Lee-Ren Yeh (Author), Yu-Ting Kuo (Author), Jeon-Hor Chen (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond-Part 2
by: Akshay D. Baheti, et al.
Published: (2019) -
Tumor Response Criteria in Oncoimaging: RECIST Criteria and beyond-Part 1
by: Ashita Rastogi, et al.
Published: (2019) -
Tumor therapeutics in the era of "RECIST": past, current insights, and future prospects
by: Zhilong Xu, et al.
Published: (2024) -
Comparison of Choi, RECIST and Somatostatin Receptor PET/CT Based Criteria for the Evaluation of Response and Response Prediction to PRRT
by: Kevin Zwirtz, et al.
Published: (2022) -
Multilingual RECIST classification of radiology reports using supervised learning
by: Luc Mottin, et al.
Published: (2023)